MAP2K5 and cancer: Here, we show that pharmacological and genetic suppression of the MEK5/ERK5 pathway markedly increased the UPR and the autophagic flux in cancer cells, indicating that ERK5 activity contributes to fine-tuning of UPR and autophagy in this context (Figures 1, 2).